
Board MeetingMay 12, 2026, 08:02 AM
Lyell Immunopharma to Present at H.C. Wainwright & Stifel Conferences
AI Summary
Lyell Immunopharma, a late-stage clinical company focused on CAR T-cell therapies for cancer, announced that its senior management team will participate in two upcoming investor conferences. The company will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026, and the 2026 Stifel Virtual Targeted Oncology Forum on May 20, 2026. Live webcasts and replays of the fireside chats will be accessible through Lyell's investor relations website.
Key Highlights
- Lyell Immunopharma senior management to participate in H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026.
- Fireside chat at H.C. Wainwright conference scheduled for 11:00 am Eastern Time.
- Company management to participate in 2026 Stifel Virtual Targeted Oncology Forum on May 20, 2026.
- Fireside chat at Stifel conference scheduled for 4:00 pm Eastern Time.
- Live webcasts and replays of both fireside chats will be available on the company's website.
Price Impact
More from LYEL